Mechanically activated (MA) ion channels convert physical forces into electrical signals. Despite the importance of this function, the involvement of mechanosensitive ion channels in human disease is poorly understood. Here we report heterozygous missense mutations in the gene encoding the MA ion channel TMEM63A that result in an infantile disorder resembling a hypomyelinating leukodystrophy. Four unrelated individuals presented with congenital nystagmus, motor delay, and deficient myelination on serial scans in infancy, prompting the diagnosis of Pelizaeus-Merzbacher (like) disease. Genomic sequencing revealed all four individuals carry heterozygous missense variants in the pore-forming domain of TMEM63A. These variants were confirmed to have arisen de novo in three of the four individuals. While the physiological role of TMEM63A is incompletely understood, it is highly expressed in oligodendrocytes and it has recently been shown to be a mechanically activated (MA) ion channel. Using patch clamp electrophysiology, we demonstrated that each of the modelled variants results in strongly attenuated stretch-activated currents when expressed in naïve cells. Unexpectedly, the clinical evolution of all four individuals has been surprisingly favorable, with substantial improvements in neurological signs and developmental progression. In the three individuals with follow-up scans after four years of age, the myelin deficit had almost completely resolved. Our results suggest a previously unappreciated role for mechanosensitive ion channels in myelin development.
Leukodystrophies are genetic disorders primarily affecting brain white matter character-1 ized by the abnormalities they demonstrate on magnetic resonance imaging (MRI) [1] [2] [3] [4] [5] [6] . 2 MRI pattern recognition often helps to obtain an MRI-based diagnosis in leukodystro- 3 phies and enables targeted genetic testing [7, 8] , but genetic heterogeneity may require a 4 more comprehensive approach. Next generation sequencing (NGS) has rapidly improved 5 the diagnosis of previously elusive or novel phenotypes with whole exome sequencing 6 (WES) and whole genome sequencing (WGS) now directly responsible for implicating a 7 large number of genes with leukodystrophies, greatly reducing the number of unsolved 8 cases [2, [9] [10] [11] [12] . 9 Myelination is a protracted developmental process that progresses in infancy following 10 a fixed pattern and is almost complete by the age of 24 months. It can be followed using 11 serial MRI scans [4, 13] . A severe deficit of myelin observed on time-separated scans is 12 classified as a hypomyelinating leukodystrophy, a large and genetically heterogeneous 13 group among the leukodystrophies [14] . Clinical presentation is often in early infancy 14 with nystagmus and axial hypotonia, evolving to ataxia and spasticity, with motor 15 development more affected than cognitive function. Alternatively, presentation later in 16 life with a milder clinical picture is also possible [15, 16] . The prototype of hypomyelinating 17 leukodystrophies is Pelizaeus-Merzbacher disease (PMD, MIM: 312080) due to alterations 18 of PLP1 (OMIM:300401), encoding the structural myelin protein, proteolipid protein 19 1 [17] . Under the age of 24 months hypomyelination cannot be diagnosed on MRI with 20 a single exam [14] . However, in the context of profound myelin deficit and a compatible 21 clinical presentation, hypomyelinating leukodystrophy may be suspected in the first year 22 of life and appropriate investigations can be started. Without a definitive diagnosis, 23 MRI should be repeated to distinguish hypomyelination from delayed myelination. 24 Here we report on four individuals who presented with a severe myelin deficit observed 25 on serial MRIs, indistinguishable from PMD in the infantile stage ( Figure 1 ), which 26 unexpectedly resolved on follow-up scans, with parallel clinical improvement. Families 27 1 & 2 were investigated as part of an on-going study on the Amsterdam Database of 28 Figure 1 . MRI evolution of individual 1. Axial T 2 -weighted images and a midsagittal T 1 -weighted image of individual 1 at 9 months and 12 years of age, shown in comparison with age-matched controls and a individual with PMD aged 9 months. At 9 months, MRI findings are indistinguishable from PMD, with supra-and infratentorial white matter signal that is diffusely elevated on the T 2 -weighted images. The corpus callosum is thinner than normal. At age 12 years, supratentorial white matter signal has normalized, but there is still mild hyperintensity of the cerebellar white matter and the middle cerebellar peduncles.
Leukoencephalopathies to unravel the genetic cause of unclassified leukodystrophies. 29 Families 3 & 4 were identified in Peking University First Hospital (Beijing, China). 30 Institutional ethics approval was granted at both participating centres and written 31 informed consent secured from the guardians of these individuals. WGS and WES 32 were performed on family trios (proband, biological mother, and biological father), for 33 Families 1 & 2 and Families 3 & 4, respectively.
34
Individual 1 is a 21-year-old male of European descent who was born at term without 35 complications after an uneventful pregnancy. At age 2 weeks, parents noted a pendular 36 nystagmus, increasing with fixation and when agitated. At the age of 2 months, he was 37 an alert baby who could follow objects, but had a tendency towards opisthotonus. In the 38 following months, his development slowly progressed, but at age 8 months, he was not 39 able to sit because of poor balance and had head titubation. He could not grasp objects 40 well due to intention tremor and dysmetria. He could move around by rolling over. His 41 nystagmus had persisted and was now fast. Brain MRI at age 9.5 months showed severe 42 myelin deficit, with no normal myelin signal of both supra-and infratentorial white 43 matter at T 1 -and T 2 -weighted images (Figures 1 and 2 ), similar to an age-matched 44 child with PMD due to PLP1 duplication (Figure 1 ). At 1 year of age, he was able to 45 sit relatively stable and started to pull himself up. Language development was normal. 46 Figure 1 for this individual) are not depicted here. Myelination shows small improvements only at age 31 months and is completed by age 4 years, whereas it is continually progressing in healthy children, to be virtually completed at age 2 years.
He walked without support at age 20 months. At 5 years, neurological examination 47 showed only mild ataxia; his nystagmus had almost disappeared. He had low vision and 48 mild myopia. Fundoscopy was normal. At age 7 years, he had an episode of vertigo, 49 without nystagmus. Both brain CT and CSF testing were normal, and vertigo improved 50 within 2 to 3 weeks. At 12 years of age, brain MRI showed normal myelin signal with 51 the exception of the middle cerebellar peduncles and the cerebellar white matter, which 52 were mildly T 2 hyperintense (Figure 1 ). At age 13 years, he had very mild ataxia with 53 suboptimal tandem gait and standing on one leg. By age 16 years, he had developed 54 optic atrophy. At that age, he developed Crohn's disease, which is stable with treatment. 55 Without cognitive problems, he visited regular school and is now a student at university. 56 Individual 2 is a 17-year-old male of European descent born at 38 weeks gestational 57 age after a pregnancy complicated by diabetes mellitus treated with insulin. Delivery was 58 by vacuum extraction, and birth weight was 4700g. Immediately post-partum, he had 59 to be resuscitated (Apgar scores 1/1/1), but did not need intubation. On day 2 of life, 60 he developed epileptic seizures, necessitating treatment and artificial ventilation. Brain 61 ultrasound was repeatedly normal. After one week, he was seizure-free and discharged at 62 age two weeks. Brain MRI at age 3 weeks showed no evidence of hypoxia related brain 63 lesions, but the normal myelin signal in the posterior limb of the internal capsule (PLIC) 64 was absent ( Figure 2 ). He received antiepileptic treatment during 3 months. Although 65 abnormal brain-stem auditory evoked potentials (BAEP) were observed, his parents 66 thought his hearing was fine. He was first seen in clinic at 4 months, where a pendular 67 Individual 3 is a 5-year-old female and is the second child of an unrelated Chinese 85 couple and has a healthy older sister. Pregnancy and delivery were uneventful. Her 86 birth weight was 3050g. Nystagmus was observed 10 days after birth and had resolved 87 by the end of the first year of life. Motor developmental delay was first noted at age 88 7 months when she still could not hold her head. Gesell development scale (Chinese 89 version) assessed at 7 months showed mild development delay. She started to walk 90 without support at age 26 months. Currently, she is able to run and jump, but falls 91 5/13 easily. Compared to her motor abilities, cognitive development was relatively spared. She 92 started to smile socially at age 2 months and recognized relatives by 4 months. Language 93 expression and understanding were normal, but her pronunciation was suboptimal. With 94 continuous improvement and no regression, she attended regular preschool with normal 95 performance. Hearing and vision were clinically intact. Physical examination performed 96 at 7 months of age demonstrated only mild hypotonia. Brain MRI performed at 3 and 97 31 months of age implied diffuse myelin deficit in both the supra-and infratentorial 98 brain white matter (Figure 2 ), compatible with a hypomyelinating leukodystrophy.
99
Individual 4, now 4 years old, is the second child of unrelated Chinese parents. 100 He was born uneventfully at term by elective cesarean section. His birth weight was 101 3600g. Physiological jaundice was observed and spontaneously subsided after one month. 102 Nystagmus was noted after birth and resolved by 14 months of age. At the age of 103 6 months, vision was decreased and myopia was diagnosed. Fundoscopy was normal. 104 Visual evoked potentials (VEP) performed at age 6 and 49 months were delayed. His 105 motor development was delayed, with some catching up after the first year of life. Head 106 control was achieved at age 10 months, sitting without support at age 16 months, 107 standing on his own at age 24 months and walking without support at age 36 months. 108 He started to speak at age 39 months and currently is able to speak long sentences, 109 but with unclear pronunciation. Gesell development scale (Chinese version) assessed at 110 age 6 months, 17 months and 50 months showed variable impairment in all domains 111 of development. On follow-up he had made developmental progression. His hearing 112 was clinically normal, though BAEP performed at age 6 months and 49 months had 113 demonstrated delayed conduction of binaural listening pathways in the brainstem and 114 increased hearing thresholds. Myopia was still present. Brain MRI performed at age 6 115 months and 13 months showed diffuse myelin deficit in the cerebral white matter, which 116 had resolved at age 50 months (Figure 2 ).
117
In all of these individuals, results of routine investigations and metabolic testing were 118 normal. PMD was suspected clinically, but PLP1 dosage was normal as were targeted 119 NGS of 115 leukodystrophy-related genes (including GJC2 ) or individual sequencing 120 of POLR3A/POLR3B in Individual 2. Complete case descriptions are available in the 121 Supplemental Data.
122
The earliest MRI in our cohort was performed at age 3 weeks in Individual 2. The 123 earliest MRIs for all affected individuals, in contrast to healthy newborns, showed no 124 myelin signal in the posterior limb of the internal capsule (PLIC) (Figure 2 ). There 125 was no progression of myelination in the ensuing months on T 2 -weighted images with 126 diffuse T 2 -hyperintense signal of both supra-and infratentorial white matter, including 127 T 2 -hyperintense white matter in the cerebellum and the pyramidal tracts and medial 128 lemniscus in the brain stem ( Figure 2) , in contrast to controls where these structures are 129 myelinated as early as 3 months ( Figure 2 ). Myelination had progressed slightly at 14 130 months (Individual 2, Figure 2 ) when the PLIC, the genu of the corpus callosum, and 131 the frontal periventricular white matter developed a signal isointense with the cortex 132 on T 2 -weighted images and the cerebellar white matter became almost isointense with 133 the cerebellar cortex. Myelination had normalized in all individuals tested, the earliest 134 by 4 years (Individual 4, Figure 2 ). The last MRI available at 12 years (Individual 1) 135 showed mildly T 2 -hyperintense signal of the cerebellar white matter and the cerebellar 136 peduncles, reflecting (permanent) white matter involvement (Figure 1 ).
137
In two independent studies, NGS detected heterozygous missense variants in TMEM63A 138 (NM 014698.2) in each of the four families, including one recurrent variant. The candidate 139 gene was posted on GeneMatcher [18] . De novo variants were identified in Individual (Gly567Ser) ], but in this case it was found to be paternally inherited. 143 The father of Individual 2 is deceased and records from his childhood were unavail-144 able to determine possible clinical similarities in the infantile period. Individual 
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Gly567Ser [20, 21] . Residues altered by the newly found variant are shown as spheres. The approximate location of the extracellular (Ex) and intracellular (In) surfaces of plasma membrane indicated by dashed black lines. The five pore lining transmembrane helices are shown in green [20] . C) Section of TMEM63A structural model looking through pore region towards the extracellular domain. Gly576 residue shown as red spheres, pink mesh indicated the predicted position the serine side-chain would occupy in the p.Gly576Ser mutant protein. Conserved residue Glu571 (shown as brown sticks) that has been shown to reduce stretch activated ion conductance when mutated to alanine in OSCA1.2 can be seen adjacent to Gly576 [20] . D) Clustal alignment of TMEM63A protein from 10 vertebrate species and the Arabidopsis homologue OSCA1.2. The residues altered in the presented individuals are highlighted in red. also found to have compound heterozygous missense variants in SLC6A9, encoding a 146 glycine transporter, that were initially investigated as candidates. However, glycine 147 uptake assays indicated these variants did not have an obvious impact on transporter 148 activity (results not shown), excluding these variants as candidate pathogenic alleles. 149 Individual 4 also has a single de novo variant [c.1936G>A p.(Ala646Thr)] in GRIA1 150 (NM 001258022.1) [19] , which has been reported with development delay without MRI 151 abnormalities. Interestingly, milestone achievement was more severely delayed in In-152 dividual 4 (Table 1) . Therefore, we suspect that variants in TMEM63A and GRIA1 153 may both contribute to his phenotype. No other candidate variants emerged from the 154 genomic analysis of these individuals.
155
The TMEM63A variants identified in this study are not present in the 1000 Genomes 156 7/13 or gnomAD human population databases and are all predicted to be damaging by multiple 157 prediction tools: SIFT, Polyphen-2, MutationTaster, M-Cap, Condel and PROVEAN 158 ( Supplemental Table) . The three mutated residues are also highly conserved across 159 vertebrate species (Figure 3 ).
160
TMEM63A is highly expressed in oligodendrocytes. Mouse Tmem63a shows sig-161 nificantly higher expression in myelinating oligodendrocytes and in microglia (http: 162 //web.stanford.edu/group/barres_lab). In a large-scale mouse phenotyping study, 163 a small but significant proportion of Tmem63a null mice demonstrate gait abnormalities 164 (www.mousephenotype.org/data/experiments?geneAccession=MGI:2384789).
165
Using a cryo-EM structure of the TMEM63A homologue OSCA1.2 from Arabidopsis, 166 we generated a model of TMEM63A protein structure using SWISS-MODEL (Figure 167 3b) [20, 21] . The Gly168 residue sits in an intracellular loop between helix 1 and helix 2 168 while both Ile462 and Gly567 are located within pore lining transmembrane helices of 169 TMEM63A. Interestingly Gly567 resides on the internal face of the pore one helix turn 170 from the conserved residue Glu571 that has been shown to reduce stretch activated ion 171 conductance when mutated to alanine in OSCA1.2 [20] . 172 We introduced the variants seen in these individuals by site directed mutagenesis 173 into TMEM63A clones purchased from Origene (NM 014698, Cat No.: RC206992). 174 Wild-type and mutant constructs were sub-cloned into an IRES mCherry vector and 175 transfected into PIEZO1-knockout Human Embryonic Kidney 293T cells. Using a 176 previously described cell-based stretch-activated channel activity assay [20, 22] , we 177 characterised the impact of each of the three variants on TMEM63A channel activity 178 (Figure 4 ). Mechanical stimulation, induced by the application of negative pressure in 179 the recording electrode, elicited stretch-activated currents in cells transfected with wild-180 type TMEM63A. However, cells transfected with each of the three TMEM63A variants 181 (Gly168Glu: N=7; Ile462Asn N=9; Gly567Ser: N=7) failed to induce stretch-activated 182 currents ( Figure 4B ), suggesting that these variants cause a loss of function.
183
The data presented here associate heterozygous variants in TMEM63A with a 184 leukodystrophy with transient myelin deficiency during infancy. All four cases had 185 clinical presentations suggestive of PMD or PMLD at an early age with nystagmus and 186 delayed motor development and MRIs demonstrating a pattern suggestive of hypomyeli-187 nation (present on serial MRIs in three individuals and profound myelin deficiency on 188 single MRIs in the other infant). However, clinical evolution in all four individuals 189 has been surprisingly favorable, with resolution of nystagmus, near-normalization of 190 neurological signs and developmental progression. Concurrent with the improvement in 191 neurological signs, MRI showed unexpected normalization. In two individuals the myelin 192 deficit appears to have completely resolved and in one individual only mild abnormalities 193 persist. The remaining individual, last imaged at 31 months, also displayed improvement 194 of myelination.
195
The distinction between hypomyelination and delayed myelination can be challenging. 196 PMD is a severe neurologic disorder characterized by hypomyelination with lasting 197 cognitive and motor deficits. Individuals with PMD may achieve small developmental 198 gains, but do not acquire sitting without support and demonstrate progressive spasticity 199 and gradual deterioration typically by 10 -12 years of age. Delayed myelination can be a 200 non-specific finding across a spectrum of infantile onset neurologic disorders. Profoundly 201 delayed myelination with slow improvement and even complete resolution of myelin 202 deficiency on MRI, has been observed in Allan-Herndon-Dudley syndrome (AHDS), due 203 to variants in MCT8 encoding a thyroid hormone transporter [4, 23] . However, in AHDS, 204 individuals typically remain severely affected, and clinical signs do not improve even 205 when there are radiologic changes that suggest normalization of the myelin deficit [23, 24] . 206 Temporally, neither MRI findings nor clinical development were compatible with PMD 207 or AHDS in individuals with variants in TMEM63A despite their early presentation, 208 thus we characterized this presentation as a transient myelin deficiency.
209
TMEM63A, also named CSC1-like protein 1, was initially suggested to be a hy-210 8/13 perosmolarity activated ion channel [25, 26] . More recently it was demonstrated that 211 TMEM63s are MA ion channels that elicit stretch-activated currents when expressed 212 in naïve cells [22] . The results described here clearly demonstrate that each of the 213 hypomyelination associated variants result in a loss of TMEM63A function either due to 214 direct effect on channel gating or due to compromised protein folding and trafficking. 215 This suggests a previously unappreciated role for TMEM63A in early myelin develop-216 ment. How disruption of this activity results in the apparently temporary myelin deficit 217 observed in these individuals is unclear. TMEM63A has two highly similar homologues 218 TMEM63B and TMEM63C. It is possible that developmental and tissue specific ex-219 pression of these homologues provide some compensation for the loss of TMEM63A 220 activity [22] .
221
Finally, our findings add TMEM63A to a growing list of leukodystrophies caused 222 by heterozygous variants, the majority of which arise de novo. Disorders that arise 223 sporadically are refractory to techniques such as linkage analysis that permit an estimation 224 of a molecular cause of disease. Trio NGS has demonstrated success in these cases, with 225 heterozygous variants in CSF1R, TUBB4A, and TMEM106B found to cause a prominent 226 leukodystrophy [9, 27, 28] .
227
Further monitoring of these individuals described in this paper will be necessary to 228 better understand the natural course of the disease related to heterozygous TMEM63A 229 variants and to reveal whether there is a risk of slow regression over time. We propose 230 a new phenotype of infantile-onset transient hypomyelination caused by heterozygous 231 TMEM63A variants, characterized by clinical and radiological normalization in childhood, 232 9/13 making this prognostically important information for affected families. It also emphasizes 233 that myelination can evolve normally even when it is initiated later than usual, giving 234 hope for therapeutic trials in hypomyelinating disorders. 235 
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A supplemental text file has been provided and includes a full description of methods 237 and expanded clinical descriptions of the described individuals.
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Supplemental Table   239 Characteristics of three variants in TMEM63A. Variant in silico prediction scores 240 for all three variants found in this study. 
